Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma.

Pierceall, William E; Amatangelo, Michael D; Bahlis, Nizar J; Siegel, David S; Rahman, Adeeb; Van Oekelen, Oliver; Neri, Paola; Young, Mary; Chung, Weiyuan; Serbina, Natalya; Parekh, Samir; Agarwal, Amit; Thakurta, Anjan

Pierceall, William E; Amatangelo, Michael D; Bahlis, Nizar J; Siegel, David S; Rahman, Adeeb; Van Oekelen, Oliver; Neri, Paola; Young, Mary; Chung, Weiyuan; Serbina, Natalya; Parekh, Samir; Agarwal, Amit; Thakurta, Anjan.

Affiliation

Pierceall WE; Bristol Myers Squibb, Summit, New Jersey.
Amatangelo MD; Bristol Myers Squibb, Summit, New Jersey.
Bahlis NJ; University of Calgary, Calgary, Alberta, Canada.
Siegel DS; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey.
Rahman A; Icahn School of Medicine at Mount Sinai, New York, New York.
Van Oekelen O; Icahn School of Medicine at Mount Sinai, New York, New York.
Neri P; University of Calgary, Calgary, Alberta, Canada.
Young M; Bristol Myers Squibb, Summit, New Jersey.
Chung W; Bristol Myers Squibb, Summit, New Jersey.
Serbina N; Bristol Myers Squibb, Summit, New Jersey.
Parekh S; Icahn School of Medicine at Mount Sinai, New York, New York.
Agarwal A; Bristol Myers Squibb, Summit, New Jersey.
Thakurta A; Bristol Myers Squibb, Summit, New Jersey. anjan.thakurta@bms.com.

Clin Cancer Res ; 26(22): 5895-5902, 2020 11 15.

Article in En | MEDLINE | ID: mdl-32928795

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Dexamethasone / Antibodies, Monoclonal / Multiple Myeloma Limits: Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2020 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google